Post-market surveillanceAndrogen Modulator
Compound 62067
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-062067
Risk Class
HIGH
Last Audit
Dec 19, 2108
Research Abstract
Androgen Modulator candidate engineered for endocrine support initiatives with automated dossier coverage.
Compound 62067 is a androgen modulator asset inside androgen modulator innovation track initiatives, optimized for endocrine support and performance longevity.
The dossier currently sits in post-market surveillance with a high risk rating, meaning it is restricted to black-box teams with hardened compliance.
Supply records cite CAS AUTO-062067 with updates logged 2108-12-19.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Endocrine supportPerformance longevity
Nomenclature
CX-62067Androgen Modulator Program 62067
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-062067
- [2] Operations Pulse • Androgen Modulator innovation track
- [3] Risk Governance Ledger • HIGH clearance for COMPOUND-62067